anmelden
FTSE All-Share
5.543,09
PKT
+1,85
PKT
+0,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.05.20 | HSBC Underweight | JP Morgan Chase & Co. | |
| 01.05.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 01.05.20 | Unilever Neutral | JP Morgan Chase & Co. | |
| 01.05.20 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Hold | Jefferies & Company Inc. | |
| 01.05.20 | Lloyds Banking Group buy | UBS AG | |
| 01.05.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 01.05.20 | Barclays buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Hold | HSBC | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.04.20 | Glencore Underweight | JP Morgan Chase & Co. | |
| 30.04.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.04.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 30.04.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 30.04.20 | GSK Underweight | Barclays Capital | |
| 30.04.20 | GSK buy | UBS AG | |
| 30.04.20 | BAT overweight | JP Morgan Chase & Co. | |
| 30.04.20 | GSK Neutral | Credit Suisse Group | |
| 30.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.04.20 | Lloyds Banking Group buy | UBS AG | |
| 30.04.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 30.04.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 30.04.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 30.04.20 | AstraZeneca Reduce | HSBC | |
| 29.04.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.04.20 | GSK buy | Goldman Sachs Group Inc. | |
| 29.04.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 29.04.20 | AstraZeneca Sell | UBS AG | |
| 29.04.20 | Barclays buy | UBS AG | |
| 29.04.20 | BP Neutral | Credit Suisse Group | |
| 29.04.20 | HSBC Neutral | Credit Suisse Group | |
| 29.04.20 | HSBC Neutral | UBS AG | |
| 29.04.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 29.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. |